Evidence map›Paper›PMID 35513537›Full record

ReviewZeitschrift fur Rheumatologie2022

[Value of CT and transthoracic lung ultrasound in patients with systemic sclerosis : Joint statement of the ÖRG/ÖGP/ÖGR/ÖGUM].

M Grohs, F C Moazedi-Fuerst, H Flick, K Hackner, A Haidmayer, S Handzhiev, H Kiener, J Löffler-Ragg, G Mathis, G Mostbeck and 3 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Zeitschrift fur Rheumatologie, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

M GrohsBVAEB - Rehabilitationszentrum Engelsbad, Weilburgstr. 7-9, 2500, Baden, Österreich.
F C Moazedi-FuerstKlinische Abteilung für Rheumatologie und Immunologie, Medizinische Universität Graz, Auenbruggerplatz 15, 8036, Graz, Österreich. florentine.fuerst@medunigraz.at.
H FlickKlinische Abteilung für Pneumologie, Medizinische Universität Graz, Auenbruggerplatz 15, 8036, Graz, Österreich.
K HacknerKlinische Abteilung für Pneumologie, Universitätsklinikum Krems, Karl Landsteiner Privatuniversität für Gesundheitswissenschaften, Mitterweg 10, 3500, Krems an der Donau, Österreich.
A HaidmayerLandeskrankenhaus Südoststeiermark, Dr.-Schwaiger-Str. 1, 8490, Bad Radkersburg, Österreich.
S HandzhievKlinische Abteilung für Pneumologie, Universitätsklinikum Krems, Karl Landsteiner Privatuniversität für Gesundheitswissenschaften, Mitterweg 10, 3500, Krems an der Donau, Österreich.
H KienerUniversitätsklinik für Innere Medizin III / Rheumatologie, Medizinische Universität Wien, Währinger Gürtel 18-20, 1090, Wien, Österreich.
J Löffler-RaggUniversitätsklinik für Innere Medizin II / Pneumologie, Tirol Kliniken GmbH - Medizinische Universität Innsbruck, Anichstr. 35, 6020, Innsbruck, Österreich.
G Mathis, Bahnhofstr. 16, 6830, Rankweil, Vorarlberg, Österreich.
G MostbeckEvangelisches Krankenhaus, Schopenhauerstr. 14, 1180, Wien, Österreich.
O SchindlerAbteilung für Innere Medizin und Pneumologie, Standort Enzenbach, LKH Graz II, Gratwein-Strassengel, Österreich.ORCID http://orcid.org/0000-0002-1838-7384
G WidmannUniversitätsklinik für Radiologie, Tirol Kliniken GmbH - Medizinische Universität Innsbruck, Anichstr. 35, 6020, Innsbruck, Österreich.
H ProschUniversitätsklinik für Radiologie und Nuklearmedizin, Medizinische Universität Wien, Währinger Gürtel 18-20, 1090, Wien, Österreich.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung involvement is the most frequent cause of death in patients with systemic sclerosis (SSc). As lung involvement is frequently asymptomatic, the current recommendation is to carry out thoracic computed tomography (CT) in all patients newly diagnosed with SSc. There is currently disagreement on how patients with SSc for whom no lung involvement was found at the time of diagnosis, should be followed up. Based on a consensus of Austrian rheumatologists, pneumologists and radiologists it is recommended that for asymptomatic patients with a negative CT at the time of initial diagnosis, a transthoracic ultrasound examination should be carried out annually and a lung function examination every 6-12 months. In the presence of a positive lung ultrasound finding a supplementary CT for further clarification is recommended. Based on the data situation, annual CT follow-up controls are recommended for patients with a high risk as defined by appropriate risk factors.

Indexed as

Scleroderma, SystemicHumansLungRisk FactorsTomography, X-Ray ComputedUltrasonographyEarly diagnosisLung involvementPulmonary fibrosisRisk factorsTransthoracic lung ultrasound

Identifiers

PMID35513537
PMCPMC9468076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.